Efficacy of linagliptin on glycemic control in diabetic patients on hemodialysis [Diamond study-1]
Not Applicable
- Conditions
- Diabetic patients on hemodialysis
- Registration Number
- JPRN-UMIN000007635
- Lead Sponsor
- Diamond study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
Patients treated with insulin Patients with severe liver dysfunction (AST >= 100 IU/L or ALT >= 100 IU/L) Patients with malignancy Patients with untreated diabetic retinopathy Patients disqualified by doctor for any reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change from baseline in HbA1c at week 12
- Secondary Outcome Measures
Name Time Method Change from baseline in glycated albumin at week 12